Arrowhead Pharmaceuticals
The Director, Contracts & Pricing leads the development, optimization, and execution of pricing and contracting strategies for Arrowhead's products across their lifecycle, ensuring competitive positioning and maximizing patient access. Reporting to the Executive Director of Market Access, this role collaborates cross‑functionally with legal, sales, finance, and other teams while providing insights on policy, reimbursement, and market dynamics.
Headquarters
Pasadena, California, United States
Company Size
501-1000 employees
Founded
2004
Arrowhead Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops, and delivers RNA interference (RNAi)-based therapeutics to silence disease-causing genes. Using proprietary targeted delivery platforms that enable focused, durable gene knockdown, Arrowhead advances programs across liver and extra‑hepatic indications including cardiometabolic, pulmonary, viral, and rare diseases. The company progresses multiple clinical and preclinical candidates and collaborates with partners to translate RNAi science into new therapies that aim to change how diseases are treated.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arrowhead Pharmaceuticals.
7% above the average for this role
Head of Contracts & Pricing
Takeda Pharmaceutical Company Limited
Associate Director, Market Access Contracting
Novartis
Director, Pricing & Contracting
iSi Environmental
Head of Contracts & Pricing
Takeda Pharmaceutical Company Limited
Associate Director, Market Access Contracting
Novartis
Executive Director, Contracts & Pricing Strategy – Oncology & Ophthalmology
Amgen